...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors
【24h】

Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors

机译:多药抗性铜绿假单胞菌在重症监护病房中降低呼吸道感染:患病率和风险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Intensive care unit (ICU) admission is a risk for multidrug-resistant (MDR) Pseudomonas aeruginosa, but factors specific to critically ill pneumonia patients are not fully characterized. Objective was to determine risk factors associated with MDR P. aeruginosa pneumonia among ICU patients. This was a retrospective case-control study of P. aeruginosa pneumonia in the ICU; cystic fibrosis and colonizers were excluded. Risk factors ihcluded comorbid conditions and prior healthcare exposure (anti-pseudomonal antibiotics, hospitalizations, nursing home, P. aeruginosa colonization/infection, mechanical ventilation). Of 200 patients, 47 (23.5%) had MDR P. aeruginosa pneumonia. Independent predictors for MDR were >= 24 h antibiotics in the preceding 90 days (carbapenems, fluoroquinolones, and piperacillin-tazobactam) (odds ratio, 3.6 195% CI, 1.6-8.1]) and nursing home residence (2.3 11.1-4.9]). MDR P. aeruginosa remains prevalent among ICU patients with pneumonia. Given poor outcomes with delayed therapy, patients should be thoroughly assessed for prior anti-pseudomonal antibiotic exposure and nursing home residency. (C) 2017 Elsevier Inc. All rights reserved.
机译:密集护理单位(ICU)入院是多药物抗性(MDR)假单胞菌铜绿假单胞菌的风险,但对危重肺炎患者的因素没有完全表征。目的是在ICU患者中确定与MDR P.铜绿假单胞菌肺炎的风险因素。这是ICU中对铜绿假单胞菌肺炎的回顾性案例研究;排除囊性纤维化和结肠剂。危险因素宜必氏合并症条件和先前的医疗暴露(抗假型抗生素,住院,养老院,P.铜绿假单胞菌定植/感染,机械通风)。 200名患者,47例(23.5%)有MDR P.铜绿假单胞菌肺炎。 MDR的独立预测因子> = 24小时前90天(CarbapeNs,Fluoroquinolones和Piperacillin-Tazobactam)(odds比率,3.6 195%Ci,1.6-8.1])和养老院住宅(2.3 11.1-4.9]) 。 MDR P. Aeruginosa在ICU肺炎患者中仍然是普遍的肺炎。考虑到延迟治疗的差,应彻底评估患者的抗假药抗生素暴露和护理家庭居住。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号